By: Tetsuya Tanimoto, MD Chairman of Accessible Railway Medical Services Tetsuikai Medical Corporation Director of Navitas Clinic Kawasaki In the ever-evolving world of metabolic health management, we stand at a peculiar, almost mystical crossroads. On one side, a line-up of cutting-edge pharmaceuticals, the stars of which are GLP-1 receptor agonists, have appeared, almost from thin air. These drugs—sleek, precise, and modern—promise a life free from constant hunger and the w

Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The new coronavirus vaccine "Costaive," developed by Meiji Seika Pharma (a subsidiary of Meiji Holdings), has garnered significant public attention. Social media is flooded with misinformation, including claims that vaccinated individuals can infect others through 'shedding'. Meiji has initiated defamation lawsuits against anti-vaccine groups that have led the spread of these falsehoods.